Home Biosimilar Antibodies Metabolism PCSK9 antibody Ralpancizumab (Anti-PCSK9) For research use only.
Not for use in humans.

Ralpancizumab (Anti-PCSK9)

Synonyms: PF-05335810

Ralpancizumab (Anti-PCSK9) is a monoclonal antibody targeting selective proprotein convertase subtilisin kexin 9 (PCSK9). It has the potential in hemorrhagic stroke, hypercholesterolemic, dyslipidemia treatment. MW 145.28 KD.

Ralpancizumab (Anti-PCSK9)

Purity & Quality Control

≥99

Choose Selective PCSK9 Inhibitors

Biological Activity

Description Ralpancizumab (Anti-PCSK9) is a monoclonal antibody targeting selective proprotein convertase subtilisin kexin 9 (PCSK9). It has the potential in hemorrhagic stroke, hypercholesterolemic, dyslipidemia treatment. MW 145.28 KD.

Product Details

CAS No. 1407495-04-8
Isotype Human IgG2SA
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ralpancizumab (Anti-PCSK9) | Ralpancizumab (Anti-PCSK9) supplier | purchase Ralpancizumab (Anti-PCSK9) | Ralpancizumab (Anti-PCSK9) cost | Ralpancizumab (Anti-PCSK9) manufacturer | order Ralpancizumab (Anti-PCSK9) | Ralpancizumab (Anti-PCSK9) distributor